ATE464553T1 - Verfahren zur herzerkrankungsbewertung in einer einzelperson - Google Patents
Verfahren zur herzerkrankungsbewertung in einer einzelpersonInfo
- Publication number
- ATE464553T1 ATE464553T1 AT03794666T AT03794666T ATE464553T1 AT E464553 T1 ATE464553 T1 AT E464553T1 AT 03794666 T AT03794666 T AT 03794666T AT 03794666 T AT03794666 T AT 03794666T AT E464553 T1 ATE464553 T1 AT E464553T1
- Authority
- AT
- Austria
- Prior art keywords
- individual
- methods
- cardiovascular disease
- heart disease
- disease assessment
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40916702P | 2002-09-09 | 2002-09-09 | |
| PCT/US2003/028135 WO2004023101A2 (en) | 2002-09-09 | 2003-09-09 | Methods of cardiovascular disease assessment in an individual |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE464553T1 true ATE464553T1 (de) | 2010-04-15 |
Family
ID=31978724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03794666T ATE464553T1 (de) | 2002-09-09 | 2003-09-09 | Verfahren zur herzerkrankungsbewertung in einer einzelperson |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7642052B2 (de) |
| EP (1) | EP1576352B1 (de) |
| JP (1) | JP4510630B2 (de) |
| AT (1) | ATE464553T1 (de) |
| AU (1) | AU2003265998A1 (de) |
| CA (1) | CA2498329A1 (de) |
| DE (1) | DE60332158D1 (de) |
| WO (1) | WO2004023101A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006031955A2 (en) | 2004-09-14 | 2006-03-23 | The Regents Of The University Of Colorado, A Body Corporate | Method for treatment with bucindolol based on genetic targeting |
| AU2011203050B2 (en) * | 2004-09-14 | 2014-08-14 | Regents Of The University Of Colorado | Method for treatment with bucindolol based on genetic targeting |
| PL3002294T3 (pl) * | 2006-06-13 | 2018-08-31 | Helix Biomedix, Inc. | Fragmenty peptydowe do indukowania syntezy białek macierzy zewnątrzkomórkowej |
| US9622669B2 (en) | 2008-06-13 | 2017-04-18 | Parkinson's Institute | Diagnosis of neurodegenerative disorders |
| RU2459583C1 (ru) * | 2011-01-24 | 2012-08-27 | Федеральное государственное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения и социального развития Российской Федерации (ФГУ "НИИ ОММ" Минздравсоцразвития России) | Способ диагностики артериальной гипертензии и транзиторной сердечной недостаточности у эмбриона в 11-14 недель |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6498009B1 (en) * | 1997-10-10 | 2002-12-24 | University Of Cincinnati | β-adrenergic receptor polymorphisms |
| DE19938390A1 (de) | 1999-08-05 | 2001-03-08 | Max Delbrueck Centrum | Neue Sequenzvarianten des menschlichen ßl-Adrenozeptorgens und ihre Verwendung |
| AU2001255448A1 (en) | 2000-04-17 | 2001-10-30 | Stephen B. Liggett | Alpha-2 adrenergic receptor polymorphisms |
| ATE489481T1 (de) * | 2003-09-12 | 2010-12-15 | Univ Cincinnati | Verfahren zur risikobeurteilung, überlebensvorhersage und behandlung von herzversagen und anderen leiden auf der grundlage von polymorphismen adrenerger rezeptoren |
-
2003
- 2003-09-09 WO PCT/US2003/028135 patent/WO2004023101A2/en active Application Filing
- 2003-09-09 EP EP03794666A patent/EP1576352B1/de not_active Expired - Lifetime
- 2003-09-09 CA CA002498329A patent/CA2498329A1/en not_active Abandoned
- 2003-09-09 JP JP2004534771A patent/JP4510630B2/ja not_active Expired - Fee Related
- 2003-09-09 AU AU2003265998A patent/AU2003265998A1/en not_active Abandoned
- 2003-09-09 AT AT03794666T patent/ATE464553T1/de not_active IP Right Cessation
- 2003-09-09 US US10/527,263 patent/US7642052B2/en active Active
- 2003-09-09 DE DE60332158T patent/DE60332158D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1576352A4 (de) | 2006-08-16 |
| US20060292565A1 (en) | 2006-12-28 |
| WO2004023101A2 (en) | 2004-03-18 |
| AU2003265998A1 (en) | 2004-03-29 |
| EP1576352A2 (de) | 2005-09-21 |
| CA2498329A1 (en) | 2004-03-18 |
| AU2003265998A8 (en) | 2004-03-29 |
| WO2004023101A3 (en) | 2006-02-09 |
| JP4510630B2 (ja) | 2010-07-28 |
| DE60332158D1 (de) | 2010-05-27 |
| EP1576352B1 (de) | 2010-04-14 |
| US7642052B2 (en) | 2010-01-05 |
| JP2006515164A (ja) | 2006-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004055519A3 (en) | Specific markers for pancreatic cancer | |
| WO2004030511A3 (en) | Prostate cancer biomarkers | |
| IS7611A (is) | Örfylki og aðferð til þess að framkvæma blöndunarhvörf fyrir fjölda sýna á einu örfylki | |
| WO2006023769A3 (en) | Determining data quality and/or segmental aneusomy using a computer system | |
| WO2005017646A3 (en) | System, software and methods for biomarker identification | |
| MX2009000914A (es) | Medios y metodos para evaluar el riesgo de intervenciones cardiacas basadas en el factor 15 de diferenciacion del crecimiento. | |
| ATE330032T1 (de) | Verfahren zur erhaltung der dns-integrität | |
| ATE480642T1 (de) | Verfahren zur bestimmung von genotoxizität | |
| ATE456666T1 (de) | Verfahren zur auswertung von ribonukleotidsequenzen | |
| DE60326748D1 (de) | Verfahren zur identifizierung des brustkrebsrisikos | |
| WO2009151757A3 (en) | Method and apparatus for forensic screening | |
| DE60321356D1 (de) | Verfahren zur diagnostik von eierstock endometriose | |
| ATE519116T1 (de) | Verfahren zur normierung der konzentration von analyten in einer urinprobe | |
| WO2005100611A3 (en) | Detection of viral nucleic acid and method for reverse transcribing rna | |
| WO2007126901A3 (en) | Apparatus and method for predicting disease | |
| NO20052553D0 (no) | Cobalaminanalyse. | |
| WO2001079541A3 (en) | Improvements in and relating to analysis of dna samples | |
| ATE464553T1 (de) | Verfahren zur herzerkrankungsbewertung in einer einzelperson | |
| WO2004113574A3 (en) | Methods for disease screening | |
| ATE543429T1 (de) | Verfahren zur bestimmung des sympathikus-tonus und messsystem dafür | |
| NO20053682D0 (no) | Fremgangsmate og utstyr for integrert analyse av en hydrokarbonprove. | |
| WO2003089901A3 (en) | Methods for preparing libraries of unique tags and related screening methods | |
| WO2005049861A3 (en) | Method for the analysis of gynaecological cell proliferative disorders | |
| DE112005001583T5 (de) | Kupfermetallisierungs-Analysesystem und -verfahren unter Verwendung von Röntgenfluoreszenz | |
| ATE515576T1 (de) | Protein c polymorphismen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |